BIO

Lydia obtained her BSc in Biomedical Science at Liverpool John Moores University in 2017. During this time, she trained as a Biomedical Scientist in histopathology at the Countess of Chester hospital and was awarded the Institute of Biomedical Science Certificate of Competence in the same year. She then moved to Spain where she worked as an editor including for a peer-reviewed journal, assisting with the publication of biomedical research articles. In 2023, she gained her Master’s in Translational Medicine at the University of Barcelona and completed her research project at Barcelona Hospital Clinic’s Institute of Biomedical Research August Pi i Sunyer (IDIBAPS). For this project she joined the Translational Control of Liver Disease and Cancer research group where she looked at the role of post-transcriptional regulatory proteins in the progression and immune response in lung cancer, using primary cell lines in vitro and transgenic mouse models. She joined the Nanomedicine Lab as a PhD student in 2023, as part of the NanoTherapeautics group to investigate nanotherapies for the immunomodulation of glioblastoma.